Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study
Anti-Cancer Drugs, 09/11/09
Benesch M et al. – Although intrathecal liposomal cytarabine was generally well tolerated, it should be used cautiously and only with dexamethasone prophylaxis in extensively pretreated patients with recurrent brain tumors. Proof of efficacy requires a prospective single–agent phase II study.
Related Articles
Brain Tumor Survivors Speak Out
Journal of Pediatric Oncology Nursing, 10/26/09
Relevance Score: 70%
Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
Journal of Neuro-Oncology, 10/26/09
Relevance Score: 70%
Endocrine Late Effects in Survivors of Pediatric Brain Tumors
Journal of Pediatric Oncology Nursing, 10/26/09
Relevance Score: 69%
Convection-enhanced delivery for the treatment of brain tumors
Expert Review of Neurotherapeutics, 10/21/09
Relevance Score: 69%
Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors
Annals of the Indian Academy of Neurology, 10/16/09
Relevance Score: 69%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A heritable predisposition to pituitary tumors
Pituitary, 12/18/09
Temozolomide (Temodar) and capecitabine (Xeloda) treatment of an aggressive corticotroph pituitary tumor
Pituitary, 12/18/09
Complete percutaneous treatment of vertebral body tumors causing spinal canal compromise using a transpedicular cavitation, cement augmentation, and radiosurgical technique
Neurosurgical Focus, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


